American Thrombosis and Hemostasis Network, Inc. – Trademark Portfolio
Entity Type: 99
American Thrombosis and Hemostasis Network, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include ROBUST HEALTH and ROBUST HEALTH BY ATHN. The owner is based in Rochester, NY.
67 Red Rock Circle
Rochester, NY 14626
Showing of trademarks Trademarks
Trademark Classifications
American Thrombosis and Hemostasis Network, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does American Thrombosis and Hemostasis Network, Inc. have?
American Thrombosis and Hemostasis Network, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does American Thrombosis and Hemostasis Network, Inc. file in?
American Thrombosis and Hemostasis Network, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are American Thrombosis and Hemostasis Network, Inc.'s most well-known trademarks?
American Thrombosis and Hemostasis Network, Inc.'s registered trademark portfolio includes well-known marks such as ROBUST HEALTH and ROBUST HEALTH BY ATHN. These are among 3 currently registered trademarks in the portfolio.
What is American Thrombosis and Hemostasis Network, Inc.'s trademark registration success rate?
American Thrombosis and Hemostasis Network, Inc. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.